Novo Nordisk s executive vice president of Development, Martin Holst Lange, expressed confidence that larger trials could reveal weight loss of up to 25%, citing data from previous studies, including stand-alone trials of cagrilintide, to support this projection
Because this nondeficient G6PD variant is polymorphic in Africa, the most likely explanation for the presence of two mutations in cis is that a second point mutation has taken place in a Gd A gene
Epidemiological literature (LeRoith 2003
Despite this, few well-designed studies have been conducted on the assessment of the potential benefits, dose regimens, or route of administration of N-acetylcysteine in non-acetaminophen liver failure
Folic acid should be used with extreme caution in patients with undiagnosed anemia